NCT03184064

Brief Summary

Large postprandial glucose responses are associated with increased risk of chronic diseases, including diabetes and cardiovascular disease. Our group have previously shown that fruit polyphenol extracts, when consumed immediately before a mixed carbohydrate meal, reduce postprandial glycaemia. The aim of this study is to investigate the effects of a blackcurrant polyphenol extract and citrus polyphenol extract (and their combination), on postprandial glycaemia, insulinaemia and gastrointestinal hormone concentrations following a mixed carbohydrate test meal. It is hypothesised that blackcurrant and citrus extracts alone will inhibit glycaemia compared to placebo, and a combination of the two will have a greater effect.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2017

Completed
7 days until next milestone

Study Start

First participant enrolled

May 30, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 12, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

August 22, 2018

Status Verified

August 1, 2018

Enrollment Period

8 months

First QC Date

May 23, 2017

Last Update Submit

August 21, 2018

Conditions

Keywords

BlackcurrantCitrusPolyphenolsGlucosePostprandialMetabolism

Outcome Measures

Primary Outcomes (1)

  • Postprandial glycaemia (iAUC 0-30 min)

    The primary endpoint is iAUC 0-30 min for plasma glucose concentrations

    30 min

Secondary Outcomes (34)

  • Postprandial glycaemia: iAUC 0-120 min

    120 min

  • Postprandial glycaemia: iCmax

    120 min

  • Postprandial glycaemia: Tmax

    120 min

  • Postprandial glycaemia: absolute concentrations at specific time points

    120 min

  • Postprandial insulinemia: iAUC 0-30 min

    30 min

  • +29 more secondary outcomes

Other Outcomes (4)

  • Food diary (estimated/unweighed)

    7-days, collected at screening

  • VAS measures of the palatability of the study drink

    10 min following the test drink

  • VAS measures of mood, satiety and digestive comfort

    120 min

  • +1 more other outcomes

Study Arms (4)

Treatment arm 1

EXPERIMENTAL

Participants will receive the placebo, blackcurrant extract (low dose), blackcurrant extract (high dose), citrus extract (low dose) at 4 separate study visits, in a random order. Visits will be separated by at least 7 days.

Dietary Supplement: Blackcurrant extract (low dose)Dietary Supplement: PlaceboDietary Supplement: Citrus extract (low dose)Dietary Supplement: Blackcurrant extract (high dose)

Treatment arm 2

EXPERIMENTAL

Participants will receive the placebo, citrus extract (low dose), blackcurrant extract (high dose), blackcurrant and citrus extracts (low dose / low dose) at 4 separate study visits, in a random order. Visits will be separated by at least 7 days.

Dietary Supplement: PlaceboDietary Supplement: Citrus extract (low dose)Dietary Supplement: Blackcurrant extract (high dose)Dietary Supplement: Blackcurrant and citrus extracts (low dose / low dose)

Treatment arm 3

EXPERIMENTAL

Participants will receive the placebo, blackcurrant extract (low dose), blackcurrant extract (high dose), blackcurrant and citrus extracts (low dose / low dose) at 4 separate study visits, in a random order. Visits will be separated by at least 7 days.

Dietary Supplement: Blackcurrant extract (low dose)Dietary Supplement: PlaceboDietary Supplement: Blackcurrant extract (high dose)Dietary Supplement: Blackcurrant and citrus extracts (low dose / low dose)

Treatment arm 4

EXPERIMENTAL

Participants will receive the placebo, blackcurrant extract (low dose), citrus extract (low dose), blackcurrant and citrus extracts (low dose / low dose) at 4 separate study visits, in a random order. Visits will be separated by at least 7 days.

Dietary Supplement: Blackcurrant extract (low dose)Dietary Supplement: PlaceboDietary Supplement: Citrus extract (low dose)Dietary Supplement: Blackcurrant and citrus extracts (low dose / low dose)

Interventions

Participants will consume a small beverage that contains blackcurrant extract (low dose) immediately before a high-carbohydrate meal.

Treatment arm 1Treatment arm 3Treatment arm 4
PlaceboDIETARY_SUPPLEMENT

Participants will consume a small beverage that contains no fruit extracts immediately before a high-carbohydrate meal.

Treatment arm 1Treatment arm 2Treatment arm 3Treatment arm 4
Citrus extract (low dose)DIETARY_SUPPLEMENT

Participants will consume a small beverage that contains citrus extract (low dose) immediately before a high-carbohydrate meal.

Treatment arm 1Treatment arm 2Treatment arm 4

Participants will consume a small beverage that contains blackcurrant extract (high dose) immediately before a high-carbohydrate meal.

Treatment arm 1Treatment arm 2Treatment arm 3

Participants will consume a small beverage that contains blackcurrant and citrus extracts (low dose / low dose)immediately before a high-carbohydrate meal.

Treatment arm 2Treatment arm 3Treatment arm 4

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18-70 years
  • Men and women

You may not qualify if:

  • Body Mass Index 18-35 kg/m2
  • Able to understand the information sheet and willing to comply with study protocol
  • Able to give informed written consent
  • Those diagnosed with Phenylketonuria (PKU)
  • Those with known or suspected food intolerances, allergies or hypersensitivity
  • Women who are known to be pregnant or who are intending to become pregnant over the course of the study
  • Women who are breast feeding
  • Participation in another clinical trial
  • Those who have donated blood within 3 months of the screening visit and participants for whom participation in this study would result in having donated more than 1500 millilitres of blood in the previous 12 months.
  • Full Blood Counts and Liver Function test results outside of the normal range.
  • Current smokers, or reported giving up smoking within the last 6 months
  • History of substance abuse or alcoholism
  • Reported history of Cardiovascular disease, diabetes (or fasting glucose ≥ 7.1 mmol/L), cancer, kidney, liver or bowel disease, gastrointestinal disorder or use of drug likely to alter gastrointestinal function
  • Unwilling to restrict consumption of specified high polyphenol foods for 48 h before the study
  • Weight change \>3kg in preceding 2 months
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Metabolic Research Unit

London, England, SE1 9NH, United Kingdom

Location

Related Publications (2)

  • Castro-Acosta ML, Smith L, Miller RJ, McCarthy DI, Farrimond JA, Hall WL. Drinks containing anthocyanin-rich blackcurrant extract decrease postprandial blood glucose, insulin and incretin concentrations. J Nutr Biochem. 2016 Dec;38:154-161. doi: 10.1016/j.jnutbio.2016.09.002. Epub 2016 Sep 14.

    PMID: 27764725BACKGROUND
  • Pinto AM, Hobden MR, Brown KD, Farrimond J, Targett D, Corpe CP, Ellis PR, Todorova Y, Socha K, Bahsoon S, Haworth C, Marcel M, Nie X, Hall WL. Acute effects of drinks containing blackcurrant and citrus (poly)phenols and dietary fibre on postprandial glycaemia, gut hormones, cognitive function and appetite in healthy adults: two randomised controlled trials. Food Funct. 2023 Nov 13;14(22):10163-10176. doi: 10.1039/d3fo03085g.

Study Officials

  • Wendy L Hall, PhD

    King's College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Incomplete block cross-over design. Each participant receives placebo plus 3 out of 4 active treatments.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2017

First Posted

June 12, 2017

Study Start

May 30, 2017

Primary Completion

February 1, 2018

Study Completion

June 1, 2018

Last Updated

August 22, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations